Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

CASBF

CanSino Biologics Inc.

USD

Set alert

Price alert · CASBF

All alert types
3.41 USD 0.00 0.00%
As of Oct 30, 2026
3.41 Day range 3.55
2.60 52-week range 5.60
YTD
-28.06%
1 year
-39.11%
Open
3.55
Prev close
3.41
Mkt cap
842.42M
Vol
1.30K
Avg vol
115
EPS
0.02
P/E
170.50
More statistics
Low
3.41
High
3.55

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for CASBF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

3.08 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

9 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-2 / 5 overall

  • DCF 1
  • Return on Equity 2
  • Return on Assets 3
  • Debt / Equity 3
  • P/E 1
  • P/B 4

Valuation

P/E 301×
FY 2016: -226×FY 2017: -163×FY 2018: -58.6×FY 2019: -82.9×FY 2020: -89.3×FY 2021: 18.9×FY 2022: -15.6×FY 2023: -3.5×FY 2024: -19.1×FY 2025: 301×
FY 2016 5y median -3.5× FY 2025
P/S 8.1×
FY 2016: 1386×FY 2017: -17677×FY 2018: 7166×FY 2019: 5658×FY 2020: 1421×FY 2021: 8.4×FY 2022: 13.8×FY 2023: 15.0×FY 2024: 8.7×FY 2025: 8.1×
FY 2016 5y median 8.7× FY 2025
P/B 1.7×
FY 2016: 53.0×FY 2017: 17.5×FY 2018: 16.1×FY 2019: 8.8×FY 2020: 5.8×FY 2021: 4.5×FY 2022: 2.1×FY 2023: 1.0×FY 2024: 1.5×FY 2025: 1.7×
FY 2016 5y median 1.7× FY 2025
P/FCF -54.9×
FY 2016: -70.8×FY 2017: -44.0×FY 2018: -28.5×FY 2019: -45.0×FY 2020: -47.8×FY 2021: 44.6×FY 2022: -4.8×FY 2023: -3.4×FY 2024: -11.5×FY 2025: -54.9×
FY 2016 5y median -4.8× FY 2025
EV/EBITDA 139×
FY 2016: -252×FY 2017: -160×FY 2018: -65.0×FY 2019: -65.9×FY 2020: -63.9×FY 2021: 17.1×FY 2022: -10.4×FY 2023: -3.5×FY 2024: -69.8×FY 2025: 139×
FY 2016 5y median -3.5× FY 2025
EV/Sales 8.2×
FY 2016: 1389×FY 2017: -17827×FY 2018: 7248×FY 2019: 5643×FY 2020: 1248×FY 2021: 7.5×FY 2022: 13.1×FY 2023: 16.9×FY 2024: 9.3×FY 2025: 8.2×
FY 2016 5y median 9.3× FY 2025
FCF Yield -1.8%
FY 2016: -1.4%FY 2017: -2.3%FY 2018: -3.5%FY 2019: -2.2%FY 2020: -2.1%FY 2021: 2.2%FY 2022: -20.8%FY 2023: -29.6%FY 2024: -8.7%FY 2025: -1.8%
FY 2016 5y median -8.7% FY 2025

Profitability

Gross Margin 66.1%
FY 2016: -530.5%FY 2017: 11406.3%FY 2018: -9939.4%FY 2019: 93.5%FY 2020: 19.0%FY 2021: 69.8%FY 2022: -18.1%FY 2023: -253.8%FY 2024: 70.4%FY 2025: 66.1%
FY 2016 5y median 66.1% FY 2025
Operating Margin -11.0%
FY 2016: -642.9%FY 2017: 10591.7%FY 2018: -12241.9%FY 2019: -8769.6%FY 2020: -1598.3%FY 2021: 45.1%FY 2022: -132.8%FY 2023: -589.6%FY 2024: -48.9%FY 2025: -11.0%
FY 2016 5y median -48.9% FY 2025
Net Margin 2.6%
FY 2016: -608.3%FY 2017: 10700.3%FY 2018: -12215.6%FY 2019: -6865.5%FY 2020: -1593.6%FY 2021: 44.5%FY 2022: -88.2%FY 2023: -429.6%FY 2024: -45.9%FY 2025: 2.6%
FY 2016 5y median -45.9% FY 2025
ROE 0.5%
FY 2016: -23.2%FY 2017: -10.6%FY 2018: -27.5%FY 2019: -10.7%FY 2020: -6.5%FY 2021: 23.9%FY 2022: -13.5%FY 2023: -28.1%FY 2024: -7.7%FY 2025: 0.5%
FY 2016 5y median -7.7% FY 2025
ROIC -1.8%
FY 2016: -17.6%FY 2017: -8.5%FY 2018: -20.1%FY 2019: -11.9%FY 2020: -6.2%FY 2021: 18.9%FY 2022: -11.0%FY 2023: -24.7%FY 2024: -5.7%FY 2025: -1.8%
FY 2016 5y median -5.7% FY 2025
ROA 0.4%
FY 2016: -15.3%FY 2017: -7.4%FY 2018: -17.4%FY 2019: -8.8%FY 2020: -5.9%FY 2021: 16.1%FY 2022: -7.9%FY 2023: -15.9%FY 2024: -4.8%FY 2025: 0.4%
FY 2016 5y median -4.8% FY 2025

Growth (YoY)

Revenue 25.1%
FY 2016: 0.0%FY 2017: -107.3%FY 2018: 287.9%FY 2019: 101.7%FY 2020: 990.0%FY 2021: 17174.8%FY 2022: -76.0%FY 2023: -66.5%FY 2024: 139.0%FY 2025: 25.1%
FY 2016 FY 2025
Operating Income 72.0%
FY 2016: 0.0%FY 2017: -21.1%FY 2018: -117.2%FY 2019: -44.5%FY 2020: -98.7%FY 2021: 587.9%FY 2022: -170.5%FY 2023: -48.7%FY 2024: 80.2%FY 2025: 72.0%
FY 2016 FY 2025
EPS (diluted) 107.2%
FY 2016: 0.0%FY 2017: -30.4%FY 2018: -193.3%FY 2019: 28.4%FY 2020: -154.0%FY 2021: 583.8%FY 2022: -147.7%FY 2023: -62.9%FY 2024: 74.5%FY 2025: 107.2%
FY 2016 FY 2025
Free Cash Flow 75.6%
FY 2016: 0.0%FY 2017: -50.9%FY 2018: -17.4%FY 2019: -1.0%FY 2020: -157.8%FY 2021: 209.6%FY 2022: -465.1%FY 2023: 48.5%FY 2024: 59.0%FY 2025: 75.6%
FY 2016 FY 2025

Financial Health

Current Ratio 3.5×
FY 2016: 5.4×FY 2017: 3.8×FY 2018: 2.1×FY 2019: 6.4×FY 2020: 13.1×FY 2021: 3.2×FY 2022: 2.6×FY 2023: 2.0×FY 2024: 2.4×FY 2025: 3.5×
FY 2016 5y median 2.6× FY 2025
Quick Ratio 3.2×
FY 2016: 5.4×FY 2017: 3.8×FY 2018: 2.0×FY 2019: 6.3×FY 2020: 12.7×FY 2021: 2.9×FY 2022: 2.4×FY 2023: 1.9×FY 2024: 2.3×FY 2025: 3.2×
FY 2016 5y median 2.4× FY 2025
Debt / Equity 0.3×
FY 2016: 0.3×FY 2017: 0.2×FY 2018: 0.3×FY 2019: 0.1×FY 2020: 0.0×FY 2021: 0.2×FY 2022: 0.4×FY 2023: 0.5×FY 2024: 0.4×FY 2025: 0.3×
FY 2016 5y median 0.4× FY 2025
Net Debt / EBITDA 0.9×
FY 2016: -0.4×FY 2017: -1.3×FY 2018: -0.7×FY 2019: 0.2×FY 2020: 8.9×FY 2021: -2.2×FY 2022: 0.5×FY 2023: -0.4×FY 2024: -4.2×FY 2025: 0.9×
FY 2016 5y median -0.4× FY 2025
Interest Coverage -2.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: -22.3×FY 2020: 0.0×FY 2021: 95.0×FY 2022: -33.1×FY 2023: -31.7×FY 2024: -6.7×FY 2025: -2.0×
FY 2016 5y median -6.7× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.1%FY 2019: 0.1%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 1.4%FY 2023: 0.1%FY 2024: 0.9%FY 2025: 0.0%
FY 2016 5y median 0.1% FY 2025
Payout Ratio 0.0%
FY 2016: -0.7%FY 2017: -7.2%FY 2018: -5.5%FY 2019: -5.6%FY 2020: -1.7%FY 2021: 0.7%FY 2022: -21.3%FY 2023: -0.2%FY 2024: -16.8%FY 2025: 0.0%
FY 2016 5y median -0.2% FY 2025

Annual · latest fiscal year ends 2025-12-31